| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.04 |